Literature DB >> 23714425

Heat-induced fibrillation of BclXL apoptotic repressor.

Vikas Bhat1, Max B Olenick, Brett J Schuchardt, David C Mikles, Brian J Deegan, Caleb B McDonald, Kenneth L Seldeen, Dmitry Kurouski, Mohd Hafeez Faridi, Mohammed M Shareef, Vineet Gupta, Igor K Lednev, Amjad Farooq.   

Abstract

The BclXL apoptotic repressor bears the propensity to associate into megadalton oligomers in solution, particularly under acidic pH. Herein, using various biophysical methods, we analyze the effect of temperature on the oligomerization of BclXL. Our data show that BclXL undergoes irreversible aggregation and assembles into highly-ordered rope-like homogeneous fibrils with length in the order of mm and a diameter in the μm-range under elevated temperatures. Remarkably, the formation of such fibrils correlates with the decay of a largely α-helical fold into a predominantly β-sheet architecture of BclXL in a manner akin to the formation of amyloid fibrils. Further interrogation reveals that while BclXL fibrils formed under elevated temperatures show no observable affinity toward BH3 ligands, they appear to be optimally primed for insertion into cardiolipin bicelles. This salient observation strongly argues that BclXL fibrils likely represent an on-pathway intermediate for insertion into mitochondrial outer membrane during the onset of apoptosis. Collectively, our study sheds light on the propensity of BclXL to form amyloid-like fibrils with important consequences on its mechanism of action in gauging the apoptotic fate of cells in health and disease.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  1,1′,2,2′-Tetraoleoyl cardiolipin (1′,3′-bis[1,2-dioleoyl-sn-glycero-3-phospho]-sn-glycerol); 1,2-Dihexanoyl-sn-glycero-3-phosphocholine; 20-mer peptide derived from the BH3 domain of Bid; 8-Anilinonaphthalene-1-sulfonate; ALS; ANS; Amyloid fibrils; Analytical light scattering; B-cell lymphoma 2; B-cell lymphoma extra large; BH1; BH2; BH3; BH3-interacting domain (death agonist); BH4; Bad; Bak; Bax; Bcl2; Bcl2 (homologous) antagonist/killer; Bcl2 homology 1 (domain); Bcl2 homology 2 (domain); Bcl2 homology 3 (domain); Bcl2 homology 4 (domain); Bcl2-associated X (protein); Bcl2-associated death (promoter); BclXL; BclXL homodimer in which the TM domain of one monomer occupies the canonical hydrophobic groove within the other monomer and vice versa in a domain-swapped trans-fashion; BclXL_transTM; Bid; Bid_BH3; CD; Circular dichroism; DHPC; DLS; Dynamic light scattering; FM; Fluorescence microscopy; ITC; Irreversible aggregation; Isothermal titration calorimetry; Kinetic trap; LIC; Ligation-independent cloning; MD; MM; MOM; Membrane insertion; Molecular dynamics; Molecular modeling; Myr; SEC; SLS; SSF; Size-exclusion chromatography; Static light scattering; Steady-state fluorescence; TMAO; TOCL; ThT; Thioflavin T; mitochondrial outer membrane; myricetin; trimethylamine N-oxide; α–β structural transition

Mesh:

Substances:

Year:  2013        PMID: 23714425      PMCID: PMC3706518          DOI: 10.1016/j.bpc.2013.04.002

Source DB:  PubMed          Journal:  Biophys Chem        ISSN: 0301-4622            Impact factor:   2.352


  81 in total

Review 1.  Protein folding and misfolding.

Authors:  Christopher M Dobson
Journal:  Nature       Date:  2003-12-18       Impact factor: 49.962

2.  Amyloid fibrils formed by the programmed cell death regulator Bcl-xL.

Authors:  Alexandre Chenal; Charlotte Vendrely; Heidi Vitrac; Johanna C Karst; Alexis Gonneaud; Clément E Blanchet; Sylvain Pichard; Elisabeth Garcia; Bénédicte Salin; Patrice Catty; Daniel Gillet; Nicolas Hussy; Christel Marquette; Christine Almunia; Vincent Forge
Journal:  J Mol Biol       Date:  2011-11-19       Impact factor: 5.469

3.  Evidence for stepwise formation of amyloid fibrils by the mouse prion protein.

Authors:  Shweta Jain; Jayant B Udgaonkar
Journal:  J Mol Biol       Date:  2008-07-26       Impact factor: 5.469

Review 4.  The role of the ubiquitin-proteasomal pathway in Parkinson's disease and other neurodegenerative disorders.

Authors:  K K Chung; V L Dawson; T M Dawson
Journal:  Trends Neurosci       Date:  2001-11       Impact factor: 13.837

5.  Rapid measurement of binding constants and heats of binding using a new titration calorimeter.

Authors:  T Wiseman; S Williston; J F Brandts; L N Lin
Journal:  Anal Biochem       Date:  1989-05-15       Impact factor: 3.365

6.  Study of the "molten globule" intermediate state in protein folding by a hydrophobic fluorescent probe.

Authors:  G V Semisotnov; N A Rodionova; O I Razgulyaev; V N Uversky; A F Gripas'; R I Gilmanshin
Journal:  Biopolymers       Date:  1991-01       Impact factor: 2.505

7.  Evidence that membrane insertion of the cytosolic domain of Bcl-xL is governed by an electrostatic mechanism.

Authors:  Guruvasuthevan R Thuduppathy; Jeffrey W Craig; Victoria Kholodenko; Arne Schon; R Blake Hill
Journal:  J Mol Biol       Date:  2006-04-06       Impact factor: 5.469

Review 8.  MAC and Bcl-2 family proteins conspire in a deadly plot.

Authors:  Laurent M Dejean; Shin-Young Ryu; Sonia Martinez-Caballero; Oscar Teijido; Pablo M Peixoto; Kathleen W Kinnally
Journal:  Biochim Biophys Acta       Date:  2010-01-18

9.  Bcl-x(L) sequesters its C-terminal membrane anchor in soluble, cytosolic homodimers.

Authors:  Seon-Yong Jeong; Brigitte Gaume; Yang-Ja Lee; Yi-Te Hsu; Seung-Wook Ryu; Soo-Han Yoon; Richard J Youle
Journal:  EMBO J       Date:  2004-05-06       Impact factor: 11.598

10.  AGGRESCAN: a server for the prediction and evaluation of "hot spots" of aggregation in polypeptides.

Authors:  Oscar Conchillo-Solé; Natalia S de Groot; Francesc X Avilés; Josep Vendrell; Xavier Daura; Salvador Ventura
Journal:  BMC Bioinformatics       Date:  2007-02-27       Impact factor: 3.169

View more
  1 in total

1.  A multi-trimeric fusion of CD40L and gp100 tumor antigen activates dendritic cells and enhances survival in a B16-F10 melanoma DNA vaccine model.

Authors:  Sachin Gupta; James M Termini; Yaelis Rivas; Miguel Otero; Francesca N Raffa; Vikas Bhat; Amjad Farooq; Geoffrey W Stone
Journal:  Vaccine       Date:  2015-08-01       Impact factor: 3.641

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.